Cargando…

The CGM Experience of Minority Adults With Type 1 Diabetes in the South Bronx

Objective: To describe the state of type 1 diabetes (T1D) in minority adults in the South Bronx, and their experience with continuous glucose monitoring (CGM). Introduction: In a recent analysis of data from the Type 1 Diabetes Exchange Registry, one notable finding was the difference in metabolic c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lozada Orquera, Faustina Alejandra, Leung, Vivien, Ortega, Susel Rodriguez
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8089927/ http://dx.doi.org/10.1210/jendso/bvab048.944

Ejemplares similares

Online Education Improves Knowledge and Confidence Related to CGM and the AGP
por: Larkin, Amy, et al.
Publicado: (2021)

MON-LB114 CGM in Cystic Fibrosis Patients to Predict Cystic Fibrosis-Related Diabetes Onset
por: Mei Hsia Pu, Mariana Zorron, et al.
Publicado: (2020)

SUN-146 Glucose Clearance (GLCL) Using Continuous Glucose Monitoring (CGM)
por: Melish, John
Publicado: (2019)

SAT-649 Comparison of the Accuracy and Concordance of 3 CGM Devices vs SMBG During Aerobic Exercise
por: Henske, Joseph A, et al.
Publicado: (2020)

SAT-126 The Relationship of Continuous Glucose Monitoring (CGM)-Derived Time-in-Range (TIR) to Hemoglobin A1c (HbA1c)
por: Vigersky, Robert, et al.
Publicado: (2019)

SAT134 CGM Use During Pregnancy Complicated By CF-Induced Diabetes
por: Mazori, Alon Y, et al.
Publicado: (2023)

PSUN229 Transitions of Care and Readmissions in Patients with Diabetes Receiving CGM at Hospital Discharge
por: Barnett, Anne, et al.
Publicado: (2022)

LBODP063 The Benefits Of Using Cgm For Intravenous Insulin Therapy
por: Bublik, Evgeniya, et al.
Publicado: (2022)

SAT115 Diabetes In Pregnancy: Evaluating Access And Usage Of Continuous Glucose Monitors (CGM) In A Medicaid Population
por: Chilukuri, Pranaya, et al.
Publicado: (2023)

PSAT277 Glucocorticoid Therapy for Management of Hypoglycemia in the context of Non-Islet Cell Tumor-Induced Hypoglycemia
por: Agarwal, Rahul, et al.
Publicado: (2022)

OR03-3 Impact of Continuous Glucose Monitoring (CGM) on Lifestyle Modifications in Individuals with Prediabetes
por: Khan, Shanzay, et al.
Publicado: (2022)

The Peruvian Experience: New-Onset Diabetes Presenting With Diabetic Ketoacidosis in Patients With COVID19 Infections
por: Ramos-Yataco, Anthony, et al.
Publicado: (2021)

MON-704 Tear Glands and the Diabetic Patient: Is It a Biomarker?
por: Momen, Donia, et al.
Publicado: (2020)

MON-649 Application of the New Cluster-Based Classification of Adult Onset Diabetes in a South Texas Veteran Population
por: Trejo, Jonathan, et al.
Publicado: (2020)

SAT-646 Do Diabetes and Hypertension Mobile Apps Overlap?
por: Wong, Jonathan, et al.
Publicado: (2020)

MON-669 Diabetic Macular Edema Thickness in Asians and Caucasians: Is There a Difference?
por: Leung, Brian, et al.
Publicado: (2020)

SAT-637 Patient-Centered Glycemic Management of Type 2 Diabetes with Mobile Applications
por: Lau, Chap-Kay K, et al.
Publicado: (2020)

MON-148 Medication Adherence Mobile Apps And Diabetes Self Management Education/Support Guidelines
por: Varkey, Mary Rithu, et al.
Publicado: (2019)

MON-150 Phone Call Reminders and Mobile Health Apps: Do They Help Our Diabetic Patients?
por: Lu, Kevin, et al.
Publicado: (2019)

ODP210 Impact of Continuous Glucose Monitoring (CGM) in the Intensive Care Units (ICUs): Accuracy, Reliability, Feasibility and Nurse Acceptance
por: del Rincon, Juan, et al.
Publicado: (2022)

MON-685 Lipodystrophy, a Forgotten Syndrome
por: Castellano, Janet Marie Colón, et al.
Publicado: (2020)

MON-144 Free Diabetes Mhealth Apps and a Patient Survey: Is Medication Adherence a Concern?
por: Wu, Gloria, et al.
Publicado: (2019)

SAT099 Should We Use HbA1c Or Continuous Glucose Monitoring (CGM) For Treatment Adjustment In Type 2 Diabetes Non-insulin Treated Patients?
por: Totomirova, Tzvetelina, et al.
Publicado: (2023)

MON-631 Quality of Life in a Pragmatic Trial of a Type 1 Diabetes Adolescent Transition Program
por: Leung, Joseph M W S, et al.
Publicado: (2020)

SUN-629 Text for Success in Gestational Diabetes: Development and User Experience Testing of a Text Messaging Program
por: Blair, Rachel A, et al.
Publicado: (2020)

Alpelisib-Induced Diabetic Ketoacidosis- A Case Report
por: Rodriguez, Lisette Patricia, et al.
Publicado: (2021)

OR14-4 Early Glomerular Hyperfiltration and Long Term Kidney Outcomes in Type 1 Diabetes: The DCCT/EDIC Experience
por: Molitch, Mark, et al.
Publicado: (2019)

SUN-LB117 Faster Acting Insulin Aspart in Patients With Gestational Diabetes Mellitus - an Early Experience From India
por: Bhattacharyya, Supratik
Publicado: (2020)

MON-LB126 A Benign and Favorable Diagnosis: Glycogen Hepatopathy Causing Transient Transaminitis During Diabetic Ketoacidosis in Type 1 Diabetes Mellitus
por: Yau, Alice, et al.
Publicado: (2020)

Characterization of Patients With Type 2 Diabetes Mellitus and COVID-19
por: Videa, Elvin Omar, et al.
Publicado: (2021)

SUN-131 Improving the Glycemic Control of Women Veterans with Poorly Controlled Diabetes with a Telephone Encounter
por: Casula, Sabina, et al.
Publicado: (2019)

17q12 Deletion Syndrome. A Rare Association Between Diabetes and Renal/Urogenital Abnormalities
por: Perdomo, Laura Sofia, et al.
Publicado: (2021)

SUN-177 House Of Carbs: The Path To Euglycemic Dka In Patients With Diabetes On Sglt2 Inhibitors
por: Islam, Julie, et al.
Publicado: (2019)

SAT-684 A Deadly Triad: Coexistence of Acute Pancreatitis, Hypertryglyceridemia and Diabetic Ketoacidosis
por: Torres Torres, Marina T, et al.
Publicado: (2020)

MON-156 Association of Adhesion Molecule with Diabetes, Diabetic Retinopathy, and Diabetic Kidney Disease
por: Siddiqui, Khalid, et al.
Publicado: (2019)

ODP211 Impact of Race and Chronic Kidney Disease on the Correlation between HbA1c and Continuous Glucose Monitoring (CGM) Glycemic Measures
por: Kaplan, Leah, et al.
Publicado: (2022)

SUN-165 The Largest Single-Center Experience of GLP-1 Receptor Agonists as a Safe and Effective Agent for the Management of Diabetes in Solid Organ Transplant (SOT) Recipients
por: Singh, Priyamvada, et al.
Publicado: (2019)

Psychological Impact of Diabetes Technology on Type 1 Diabetes Pregnancy
por: Less, Jacob, et al.
Publicado: (2021)

OR08-05 Sex and Ethnic Differences in Advanced Lipoprotein Profiles in South Asians, African-Americans, and Caucasians
por: Sarcone, Camila, et al.
Publicado: (2020)

MON-123 Atypical Diabetes Mellitus or Type 1 Diabetes Mellitus?
por: Havrylyan, Andriy, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_llk75lursfl6u2sk6qrl5o9s50